These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31586053)

  • 1. Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.
    Zhong Y; Lee K; Deng Y; Ma Y; Chen Y; Li X; Wei C; Yang S; Wang T; Wong NJ; Muwonge AN; Azeloglu EU; Zhang W; Das B; He JC; Liu R
    Nat Commun; 2019 Oct; 10(1):4523. PubMed ID: 31586053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive renal protective effects between arctigenin and puerarin in diabetic kidney disease.
    Li X; Wang J; Yan J; He JC; Li Y; Zhong Y
    Biomed Pharmacother; 2024 Feb; 171():116107. PubMed ID: 38215692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
    Zhang J; Cao P; Gui J; Wang X; Han J; Wang Y; Wang G
    Life Sci; 2019 Apr; 223():194-201. PubMed ID: 30898648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin attenuates diabetic kidney injury through the suppression of NOX4 expression in podocytes.
    Li X; Cai W; Lee K; Liu B; Deng Y; Chen Y; Zhang X; He JC; Zhong Y
    Sci Rep; 2017 Nov; 7(1):14603. PubMed ID: 29097815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.
    Tanabe K; Lanaspa MA; Kitagawa W; Rivard CJ; Miyazaki M; Klawitter J; Schreiner GF; Saleem MA; Mathieson PW; Makino H; Johnson RJ; Nakagawa T
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1151-60. PubMed ID: 22338086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podoplanin mediates the renoprotective effect of berberine on diabetic kidney disease in mice.
    Yu J; Zong GN; Wu H; Zhang KQ
    Acta Pharmacol Sin; 2019 Dec; 40(12):1544-1554. PubMed ID: 31270434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 11. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
    Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
    Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
    Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
    Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
    Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arctigenin protects against steatosis in WRL68 hepatocytes through activation of phosphoinositide 3-kinase/protein kinase B and AMP-activated protein kinase pathways.
    Chen KY; Lin JA; Yao HY; Hsu AC; Tai YT; Chen JT; Hsieh MC; Shen TL; Hsu RY; Wu HT; Wang GH; Ho BY; Chen YP
    Nutr Res; 2018 Apr; 52():87-97. PubMed ID: 29525610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of linalool on inflammation, matrix accumulation and podocyte loss in kidney of streptozotocin-induced diabetic rats.
    Deepa B; Venkatraman Anuradha C
    Toxicol Mech Methods; 2013 May; 23(4):223-34. PubMed ID: 23193997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages directly mediate diabetic renal injury.
    You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum amyloid A and inflammation in diabetic kidney disease and podocytes.
    Anderberg RJ; Meek RL; Hudkins KL; Cooney SK; Alpers CE; Leboeuf RC; Tuttle KR
    Lab Invest; 2015 Mar; 95(3):250-62. PubMed ID: 25531567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity.
    He JY; Hong Q; Chen BX; Cui SY; Liu R; Cai GY; Guo J; Chen XM
    Acta Pharmacol Sin; 2022 Feb; 43(2):342-353. PubMed ID: 34811512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.